Annovex Pharma, Inc.

Form 483 issued May 27, 2026 · Lorton, Virginia

Inspection
May 27, 2026
Observations
2
Pages
4
FEI number
3020928491

In short: On May 27, 2026, FDA issued a Form 483 with 2 observations to Annovex Pharma, Inc. in Lorton, Virginia (FEI 3020928491) after an inspection that ran May 27, 2026. The investigator was Christina K. Theodorou. Most observations concern facilities & equipment and quality system.

At a glance

Facilities & equipment and quality system account for 2 of 2 observations.

Facilities & equipment1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Aseptic processing areas are deficient regarding systems for maintaining any equipment used to…

  2. 02

    Records are not maintained so that data therein can be reviewed at least annually to evaluate…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Annovex Pharma, Inc.?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment and quality system. The opening words of each observation are shown on this page.

Who inspected Annovex Pharma, Inc.?

Christina K. Theodorou is named on this Form 483, for the inspection of May 27, 2026. Each investigator has a profile showing what they cite most.

When was Annovex Pharma, Inc. inspected by FDA?

The inspection ran May 27, 2026, and the Form 483 is dated May 27, 2026.

How do I get the full Form 483 for Annovex Pharma, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free